01 January 2005
Raloxifene does not prevent fi brinogen oxidation in vitro
Margit Blasbichler, Arsineh Arakil-Aghajanian, Helmut SinzingerMed Sci Monit 2005; 11(1): PI1-4 :: ID: 13882
Abstract
Background: Modifi cation of proteins may play a central role in a great variety of pathophysiological processes.It has already been ascertained that raloxifene (LY 139481), a selective estrogen receptor modulator (SERM), is an effective inhibitor of LDL oxidation. herefore, we examined potential anti-oxidant activity related to the oxidation of the glycoprotein fi brinogen.Materials/Methods: In this study we investigated whether raloxifene is able to inhibit in vitro iron-mediated oxidation of fi brinogen. We tested three different concentrations of raloxifene (5, 10, and 125 µM) corresponding to the usual dosage in postmenopausal women of between 10 and 300 mg/day, choosing two incubation periods (60 and 120 min).Results: Our results in the examined dose-range provide no evidence that raloxifene is able to prevent ironinduced fi brinogen oxidation in vitro. Considering the chemical structure of the glycoprotein fi - brinogen, it is likely that raloxifene is unable to attack a particle without lipophilic properties, although the site of its action on LDL is still unknown.Conclusions: Our data suggest that raloxifene, in contrast to its effect on LDL, lacks the capability to inhibit the oxidation of fi brinogen. The biological relevance of this fi nding still needs to be assessed in vivo.
Keywords: Fibrinogen - chemistry, Raloxifene - chemistry, Antioxidants - chemistry, Fibrinogen - chemistry, Iron - chemistry, Oxidation-Reduction, Raloxifene - chemistry
Editorial
01 April 2024 : Editorial
Editorial: Forty Years of Waiting for Prevention and Cure of HIV Infection – Ongoing Challenges and Hopes for Vaccine Development and Overcoming Antiretroviral Drug ResistanceDOI: 10.12659/MSM.944600
Med Sci Monit 2024; 30:e944600
In Press
06 Mar 2024 : Clinical Research
Comparison of Outcomes between Single-Level and Double-Level Corpectomy in Thoracolumbar Reconstruction: A ...Med Sci Monit In Press; DOI: 10.12659/MSM.943797
21 Mar 2024 : Meta-Analysis
Economic Evaluation of COVID-19 Screening Tests and Surveillance Strategies in Low-Income, Middle-Income, a...Med Sci Monit In Press; DOI: 10.12659/MSM.943863
10 Apr 2024 : Clinical Research
Predicting Acute Cardiovascular Complications in COVID-19: Insights from a Specialized Cardiac Referral Dep...Med Sci Monit In Press; DOI: 10.12659/MSM.942612
06 Mar 2024 : Clinical Research
Enhanced Surgical Outcomes of Popliteal Cyst Excision: A Retrospective Study Comparing Arthroscopic Debride...Med Sci Monit In Press; DOI: 10.12659/MSM.941102
Most Viewed Current Articles
17 Jan 2024 : Review article
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
14 Dec 2022 : Clinical Research
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
16 May 2023 : Clinical Research
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952